Acacia Pharma

Acquired by Eagle Pharmaceuticals / EURONEXT: ACPH
Develops nausea treatments for surgical and cancer patients.

F-Prime Team

Sector

Life Sciences

Category

Therapeutics

Location

Cambridge, United Kingdom

Initial Investment

2013
Develops nausea treatments for surgical and cancer patients.

Acacia Pharma (EURONEXT: ACPH) is a commercially driven hospital pharmaceutical group focused on the development and commercialisation of new nausea and vomiting treatments for surgical and cancer patients. Acacia developed BARHEMSYS to marketing approval and was acquired by Eagle Pharmaceuticals in 2022.